(Q41148925)

27 September 2017

Inhibition of bovine immunodeficiency virus by anti-HIV-1 compounds in a cell culture-based assay (English)

1 reference

Bovine immunodeficiency virus

27 September 2017

object named as

bovine immunodeficiency virus

1 reference

Tobin GJ

1

1 reference

27 September 2017

Ennis WH

series ordinal

2

1 reference

27 September 2017

Clanton DJ

series ordinal

3

1 reference

27 September 2017

Gonda MA

series ordinal

4

1 reference

27 September 2017

1 December 1996

1 reference

27 September 2017

1 reference

27 September 2017

33

1 reference

27 September 2017

1

1 reference

27 September 2017

21-31

1 reference

Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Immunological characterization of the gag gene products of bovine immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Bovine immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Characterization and molecular cloning of a bovine lentivirus related to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Bovine immunodeficiency virus: molecular biology and virus-host interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Quinobene, a new potent anti-HIV agent

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Bovine immunodeficiency virus: immunochemical characterization and serological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Antiviral activities of hypericin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Comparative evaluation of bovine immunodeficiency-like virus infection by reverse transcriptase and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Hypericin as an inactivator of infectious viruses in blood components.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Molecular targets for AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Quantitative infectivity assay for HIV-1 and-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Encephalitis, lymphoid tissue depletion and secondary diseases associated with bovine immunodeficiency virus in a dairy herd

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Amino acid sequence analysis of the proteolytic cleavage products of the bovine immunodeficiency virus Gag precursor polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Infection of rabbits with bovine immunodeficiency-like virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Isolation of a Virus From Cattle With Persistent Lymphocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

Humoral immune response to the bovine immunodeficiency-like virus in experimentally and naturally infected cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

In vitro susceptibility of clinical isolates of HIV-1 to XM323, a non-peptidyl HIV protease inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2900990-4

7 January 2021

10.1016/S0166-3542(96)00990-4

Identifiers

DOI

1 reference

27 September 2017

1 reference